Amundi Asset Management US’s PetMed Express PETS Stock Holding History

Amundi Asset Management US’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-118,696	Closed	-$13.7M	–	1680
2019 Q2	$13.7M	Buy	118,696 +10,075	+9%	+$198K	0.01%	691
2019 Q1	$2.48M	Buy	+108,621	New	+$2.45M	﹤0.01%	1054

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Amundi Asset Management US's PETS Position: Q3 2019 in Review

Amundi Asset Management US sold out of PetMed Express (PETS) in Q3 2019, closing a stake of 118,696 shares — an estimated $13.7M sold.

Amundi Asset Management US first reported a position in PETS in Q1 2019 and held it in 2 quarters. The position peaked at $13.7M in Q2 2019. 170 funds tracked by Wall St. Rank hold PETS as of Q3 2019.

Amundi Asset Management US reported no remaining PetMed Express position as of Q3 2019 after selling out during the quarter.
Amundi Asset Management US sold 118,696 PetMed Express shares in Q3 2019, an estimated $13.7M.
Amundi Asset Management US first reported a position in PetMed Express in Q1 2019 and held it in 2 quarters.
Amundi Asset Management US's PetMed Express position peaked at $13.7M in Q2 2019.
170 funds tracked by Wall St. Rank held PetMed Express as of Q3 2019.

Based on Amundi Asset Management US's 13F filing for Q3 2019, filed 14 Nov 2019.